Trial Profile
Pharmacokinetic Interaction Between Ritonavir and Prasugrel in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ritonavir (Primary)
- Indications Acute coronary syndromes; Embolism and thrombosis; HIV infections; Sickle cell anaemia
- Focus Pharmacokinetics
- 05 Oct 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
- 04 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2011 New trial record